Neumora Therapeutics Stock (NASDAQ: NMRA) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 601.991K |
Day Range | - - - |
52 Wk Range | 8.820 - 21.000 |
Market Cap | $1.559B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 7.04% |
Days to Cover | 8.82 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Neumora Therapeutics (NASDAQ: NMRA) through any online brokerage.
Other companies in Neumora Therapeutics’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), ANI Pharmaceuticals (NASDAQ:ANIP) and Longboard Pharmaceuticals (NASDAQ:LBPH).
The latest price target for Neumora Therapeutics (NASDAQ: NMRA) was reported by RBC Capital on Thursday, March 28, 2024. The analyst firm set a price target for 31.00 expecting NMRA to rise to within 12 months (a possible 217.30% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Neumora Therapeutics (NASDAQ: NMRA) is $9.77 last updated May 9, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Neumora Therapeutics.
Neumora Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Neumora Therapeutics.
Neumora Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.